Alluvi bpc 157 & tb 500 dual compound formulation brings together two peptides commonly explored in scientific research environments for their role in biological repair mechanisms and recovery processes
Achilles Tendon: Improved recovery, strength, collagen formation, and reduced inflammation in mice with torn Achilles tendon (1) Medial Collateral Ligament (MCL): Sped up healing equally across oral, topical, and injectable administration (2) Tendon-to-Bone Repair: Promoted healing even with corticosteroid use, which typically impairs recovery (3) Muscle Regeneration: Accelerated repair and restored function in quadriceps and crushed muscle injuries (4, 5, 6) Bone Fractures: Enhanced bone regeneration, likely by stimulating angiogenesis and reducing inflammation (7) Wound Healing BPC-157 speed up wound healing in animal models by improving key processes: Building New Tissue: Enhances granulation tissue formation (the early stage of healing) and collagen production (the protein that gives structure to tissues) Controlling Inflammation: Controls excessive inflammation, preventing delayed healing Growing New Blood Vessels: Supports new blood vessel growth, ensuring oxygen and nutrient delivery The combined triad of collagen-inflammatory cellsangiogenesis was accordingly upgraded, appearing at earlier intervals, more rapid, and advanced with BPC 157 therapy. (8) These improvements have been seen in various types of wounds, suggesting BPC-157 may have a broad healing effect
My only gripe is the COA could have more detail
In 2025, we saw [GLP-1] use expand well beyond type 2 diabetes, with growing attention to cardiometabolic outcomes/cardiovascular risk, arthritis, sleep apnea and liver disease
What We Offer: Personalized Plans No two people experience back pain the same way
Q: Can both forms treat B12 deficiency effectively
